As revealed by Essop et al
We studied 54,178 adults with type 2 diabetes who had been on a GLP-1 medication for at least 90 days, experienced improvement in their HbA1c results while on the treatment, and subsequently stopped the GLP-1
Insulin is a hormone that is made in the pancreas
According to the company, the compound demonstrated approximately 15% weight loss in preclinical testing, compared with roughly 9% observed with liraglutide, while food intake reductions reached approximately 39% versus around 20% for the comparator
These include oral leptin mimetics and intranasal leptin, both of which are in preclinical stages of drug development [15,45,46]
Tenderness and sensitivity in the treatment area is normal and generally subsides within a few days